This man is really good here is the link to his YT page
https://www.youtube.com/c/Campbellteaching
https://www.bmj.com/content/376/bmj.o702
https://www.bmj.com/company/the-story...
https://journals.bmj.com/home
Evidence based medicine has been corrupted by corporate interests, failed regulation, and commercialisation of academia,
argue these authors Jon Jureidini, research leader https://www.adelaide.edu.au/directory...
Research Leader, child psychiatrist Adelaide
Leemon B. McHenry, professor emeritus
Emeritus Professor, Cal State University
Not commissioned, externally peer reviewed Solid scientific foundation for medicine Validity of this new paradigm
Reliable data from clinical trials, Mostly conducted by the pharmaceutical industry THE JAPANESE JOURNAL OF ANTIBIOTICS 74―1 61( 61 )
http://jja-contents.wdc-jp.com/pdf/JJ...
Global trends in clinical studies of ivermectin in COVID-19
Morimasa Yagisawa, Patrick J. Foster, Hideaki Hanaki, Satoshi Ōmura Kitasato University asked Merck & Co., Inc. to conduct clinical trials of ivermectin for COVID-19 in Japan.
This company has priority to submit an application for an expansion of ivermectin’s indications, since the original approval for the manufacture and sale of ivermectin was conferred to it. However, the company said that it had no intention of conducting clinical trials. The release into the public domain of previously confidential pharmaceutical industry documents, valuable insight into the degree to which industry sponsored clinical trials are misrepresented. Until this problem is corrected, evidence based medicine will remain an illusion.
Karl Popper
Critical rationalism, advocated for the integrity of science and its role in an open, democratic society A science of real integrity
practitioners are careful not to cling to cherished hypotheses,
and take seriously the outcome of the most stringent experiments This ideal is, however, threatened by corporations,
financial interests trump the common good Medicine is largely dominated by a small number of very large pharmaceutical companies, that compete for market share, but are effectively united in their efforts to expanding that market. Scientific progress is thwarted by the ownership of data and knowledge because industry suppresses negative trial results, fails to report adverse events, and does not share raw data with the academic research community.
Patients die because of the adverse impact of commercial interests on the research agenda, universities, and regulators.
Hierarchical power structures, product loyalty, and public relations propaganda over scientific integrity. Universities, have adopted a neo-liberal market approach, actively seeking pharmaceutical funding on commercial terms. As a result, university departments become instruments of industry:
through company control of the research agenda, and ghostwriting of medical journal articles and continuing medical education, academics become agents for the promotion of com
